Production Description: +TPU material with mark and it can be visiable under X Ray +The catheter has a smooth side hole to ensure smooth drainage +Unique elbow design
Application Applied for internal drainage from the uretropelvic junction to the bladder, as a provisional measure. Features Made of soft telecoflex polyuretharie for Smooth Passage radio-opeque implant. Use For single use Packing Tyvek pouch as per EN-868-5 series standard Sterilizations With Ethylene Oxide EN-550 series standard Packing Area Class 100 as per ISO 14644-1 Double Pigtail Ureteral Stent with Pusher ( White / Blue Color ) Size Product No. Length Compatible Guide Wire.. 4.5 FR NMS-DJ-4.5 FR 26(CE) 26 cms. 0.025" 4.5 FR NMS-DJ-4.5 FR 26(BEO) 26 cms. 0.025" 4.8 FR NMS-DJ-4.8 FR 26(CE) 26 cms. 0.032" 4.8 FR NMS-DJ-4.8 FR 26(BEO) 26 cms. 0.032" 5 FR NMS-DJ-5 FR 26(CE) 26 cms. 0.035" 5 FR NMS-DJ-5 FR 26(BEO) 26 cms. 0.035" 5.5 FR NMS-DJ-5.5 FR 26(CE) 26 cms. 0.035" 5.5 FR NMS-DJ-5.5 FR 26(BEO) 26 cms. 0.035" 6 FR NMS-DJ-6 FR 26(CE) 26 cms. 0.038" 6 FR NMS-DJ-6 FR 26(BEO) 26 cms. 0.038" .
Double J Stent
Double J Stent
Special features and strong points -material : nitinol(nickel+titanium), shape memory property -anti-migration shape -flexible construction to conform to anatomy -dynamic radial force for maximum lumen size -retrievable -each of two radiopaque markers at both ends of stent Soft box paking in carton
Various Stents
The EverFlex stent is designed for use in the treatment of peripheral arterial disease (PAD), specifically in the iliac arteries. Key features of the EverFlex Protege stent may include: Self-Expanding Design: The stent is self-expanding, meaning it can open and conform to the shape of the artery without the need for balloon inflation. Nitinol Construction: The stent is typically made of nitinol, a nickel-titanium alloy known for its flexibility and ability to maintain shape memory. Longitudinal Flexibility: The stent is designed to provide longitudinal flexibility, allowing it to adapt to the natural movement of the vessel. Iliac Artery Treatment: The EverFlex Protege stent is specifically indicated for use in the iliac arteries, which are located in the pelvis.
Terumo is a well-known medical device company, and Ultimaster is a brand associated with their drug-eluting stent (DES) products. Drug-eluting stents are devices used in interventional cardiology to treat coronary artery disease.
Biosensors is a medical device company known for its innovations in interventional cardiology, particularly in the field of coronary stents. The BioMatrix platform includes a range of drug-eluting stents (DES) designed to be used in the treatment of coronary artery disease. Key features of the BioMatrix stent platform, which may extend to the NeoFlex model if it's a part of the series, may include: Drug-Eluting Stent: The stents in the BioMatrix platform are drug-eluting, meaning they are coated with a medication (such as an anti-restenotic drug) designed to inhibit the regrowth of tissue inside the treated blood vessel. Biodegradable Polymer: Some versions of the BioMatrix stent use a biodegradable polymer to deliver the drug to the target site. The polymer gradually dissolves over time, leaving only the metallic stent behind. Flexible Design: The stents are designed to be flexible, allowing for easier navigation and deployment in the coronary arteries. Thin-Strut Technology: Thin struts can contribute to improved deliverability and conformability of the stent to the vessel wall. Various Sizes: The BioMatrix stent platform typically offers stents in various sizes to accommodate different patient anatomies and lesion characteristics.
the Boston Scientific Promus Elite is a coronary drug-eluting stent system. It is designed for use in patients undergoing percutaneous coronary intervention (PCI) procedures to treat coronary artery disease. Here are some key features and points related to the Boston Scientific Promus Elite coronary stent: Drug-Eluting Stent: The Promus Elite is a drug-eluting stent (DES), meaning it is coated with medication to help prevent the re-narrowing (restenosis) of the treated coronary artery. Drug Coating: The stent typically features a polymer coating containing an anti-proliferative drug. This drug is slowly released over time to inhibit the growth of tissue inside the stent, reducing the risk of restenosis. Cobalt Chromium Alloy: The stent is often made of a cobalt chromium alloy, known for its strength and flexibility. This material allows for a thin stent strut design, which can be beneficial in terms of deliverability and conformability. Delivery System: The stent is delivered to the target area using a catheter-based delivery system. The catheter is guided through the blood vessels to the site of the coronary artery lesion. Radiopaque Markers: Radiopaque markers on the stent aid in proper placement and visualization under X-ray guidance during the procedure.
The "SpiderFX" may refer to a specific type of embolic protection device used during carotid artery stenting procedures. Embolic protection devices are designed to capture and remove debris released during the stenting process to prevent it from traveling to the brain, reducing the risk of stroke.
it's common for medical device companies like Medtronic to manufacture guiding catheters used in various interventional procedures, including cardiovascular interventions. Guiding catheters are medical devices used to guide and support the delivery of other interventional devices, such as angioplasty balloons, stents, or embolic protection devices, during procedures like angiography and angioplasty.
Material Number: M0031681890 Description: Straight, 2-tip marker Total / Distal Length: 150cm/6.0cm The Excelsior SL-10 Microcatheter with Thin Wall Technology and Lubricious Hydrolene�® Outer Surface is designed to provide outstanding performance 1.7F (0.56mm) Low Profile Distal Shaft, Excelsior SL-10 Microcatheter is designed with a low profile tip to enhance access to distal vasculature and ease of passage of the catheter trip through stent interstices. Atraumatic Distal Tip, Specifically engineered for atraumatic access, the rounded, low-durometer, unbraided tip offers exceptional softness and flexibility. Variety of Tip Shapes, Offered in six clinically relevant shapes to improve access and navigability.
Terumo Runthrough NS PTCA is a medical device designed for use in percutaneous transluminal coronary angioplasty (PTCA) procedures. PTCA is a minimally invasive procedure used to treat coronary artery disease by widening narrowed or blocked coronary arteries. Here are some key points about the Terumo Runthrough NS PTCA: Manufacturer: Terumo Corporation is a Japanese company known for its medical devices and healthcare products. Type: The Runthrough NS PTCA is a guide wire used in PTCA procedures. Guide wires are essential tools that help navigate catheters and other interventional devices through blood vessels during angioplasty. Function: The guide wire assists in guiding and positioning the catheter within the coronary arteries. It helps the interventional cardiologist navigate through the blood vessels and reach the site of the blockage or narrowing. Features: The "NS" in Runthrough NS may refer to "non-support" or "normal support," indicating the level of support provided by the guide wire. The choice of guide wire depends on factors such as the location and severity of the arterial blockage. Usage: The Terumo Runthrough NS PTCA guide wire is specifically designed for use in PTCA procedures to help facilitate the placement of angioplasty balloons and stents.
he Terumo Runthrough NS PTCA (Percutaneous Transluminal Coronary Angioplasty) guide wire is a product manufactured by Terumo Corporation, a global medical device company. Guide wires are essential tools used in cardiovascular procedures, particularly in angioplasty and stenting, to navigate through blood vessels and provide support for the delivery of catheters and other interventional devices. Key features and characteristics of the Terumo Runthrough NS PTCA guide wire may include: Hydrophilic Coating: Many Terumo guide wires, including the Runthrough NS, are known for their hydrophilic coating. This coating facilitates smoother navigation through blood vessels, reducing friction and enhancing steerability. Flexible Design: The guide wire is designed to be flexible, allowing it to navigate tortuous vessels and reach target locations with precision. Radiopaque Tip: The tip of the guide wire is often radiopaque, making it visible under fluoroscopy or other imaging modalities. This feature helps interventional cardiologists visualize the position of the guide wire during the procedure. Different Tip Configurations: Guide wires may come with different tip configurations, such as soft or floppy tips for ease of navigation or more supportive tips for crossing lesions. Various Lengths and Diameters: Terumo typically offers guide wires in various lengths and diameters to accommodate different patient anatomies and procedural requirements.
The EV3 SpiderFX is commonly associated with the SpiderFX Embolic Protection Device, which is used in the field of interventional cardiology. The device is designed to capture and remove embolic debris that may be released during certain vascular procedures, particularly during carotid artery stenting. Key features of the EV3 SpiderFX Embolic Protection Device may include: Embolic Protection: The primary function of the device is to provide protection against embolic debris dislodged during the intervention. It helps prevent these debris from reaching and potentially blocking smaller blood vessels. Flexible Design: The SpiderFX typically has a flexible design that allows it to navigate through blood vessels, facilitating the deployment and retrieval process. Distal Protection: The device is designed to be positioned distal to the treatment site, capturing any embolic debris before it can travel downstream. Capture Basket: The device often includes a capture basket that traps and retains embolic debris, preventing it from causing harm in the circulation. Compatibility: The SpiderFX device is designed for compatibility with various catheters and guide wires commonly used in interventional procedures.
With XIENCE Sierra's new stent design, the XIENCE reputation now extends to offer unmatched deliverability, even with challenging complex lesions. ULTRA LOW STENT CROSSING PROFILE1 OF 0.039â?³ FOR EASIER CROSSING enabled by the new stent design and balloon technology1 XIENCE Sierra's exceptional deliverability also comes from the enhanced stent delivery system featuring a single-piece outer member for added pushability and trackability. Expanded Treatment Optionsâ?¡ With 5.5 mm post-dilatation capability for 3.5 mm and 4.0 mm stents, XIENCE Sierra can treat most large vessels. PROVIDES UNSURPASSED PRECISION IN PLACEMENT AND AVOID GEOGRAPHIC MISS zero shortening even at max expansion of 5.5 mm2 XIENCE SIERRA ENSURES COATING INTEGRITY3 even at max expansion XIENCE Sierra coating remains intact at maximum post-dilatation expansion of 5.5 mm from 3.5 mm XIENCE Sierra (3.5 x 18 mm) 25x magnification at max expansion of 5.5 mm XIENCE Sierra (3.5 x 18 mm) 150x magnification at max expansion of 5.5 mm Synergy coating shows multiple cracks with delamination at its max expansion of 4.25 mm from 3.5 mm Xience Xpedition represents a powerful combination of deliverability, strong clinical data and broad availability of meaningful sizes, three factors that make this product well-suited to treat a wide range of patients, The impact of the changes to the stent delivery system is particularly notable in patients with complex coronary anatomy. For these patients, physicians have a new technology to reach the blockage and restore blood flow with ease and confidence. In order to cater the variegated demands of our beloved clients, we are offering a wide range of Abbott Xience Xpedition Stent
NEW XIENCE SIERRA STENT DESIGN The new XIENCE Sierra Stent Design, with Slim Flex Technology, has a lower crossing profile1 and greater post-dilatation expansion NEW STENT DELIVERY SYSTEM FOR COMPLEX CASES Design innovations built to provide the flexibility, crossability, and pushability needed for even the most complex cases. The XIENCE V®, XIENCE nano®, XIENCE PRIME®, XIENCE PRIME® LL, XIENCE Xpedition®, XIENCE Xpedition® SV and XIENCE Xpedition® LL , XIENCE Alpine®, and XIENCE SierraTM (XIENCE Family) of Everolimus Eluting Coronary Stents on the MULTI-LINK VISION® or MULTI-LINK MINI VISION® Delivery System INDICATIONS The XIENCE Sierra stent system is indicated for improving coronary artery luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions (length â?¤ 32 mm) with reference vessel diameters of â?¥ 2.25 mm to â?¤ 4.25 mm. In addition, the XIENCE Sierra stent system is indicated for treating de novo chronic total coronary occlusions. CONTRAINDICATIONS The XIENCE Sierra stent system is contraindicated for use in: Patients who cannot tolerate, including allergy or hypersensitivity to, procedural anticoagulation or the post-procedural antiplatelet regimen. Patients with hypersensitivity or contraindication to everolimus or structurally related compounds, or known hypersensitivity to stent components (cobalt, chromium, nickel, tungsten, acrylic, fluoropolymers), or with contrast sensitivity. WARNINGS It is not recommended to treat patients having a lesion that prevent complete inflation of an angioplasty balloon. Judicious patient selection is necessary because the use of this device carries the associated risk of stent thrombosis, vascular complications, and/or bleeding events. This product should not be used in patients who are not likely to comply with the recommended antiplatelet therapy.
The second-generation Xience V everolimus-eluting stent incorporates advanced design features such as a cobalt-chromium stent platform coated with an antirestenotic drug, everolimus, incorporated into a biocompatible polymer with a long history of medical use. The efficacy of the stent has been demonstrated with low rates of angiographic restenosis, whilst randomized trials comparing the Xience V everolimus-eluting stent to the first-generation Taxus paclitaxel-eluting stent have found a reduction in repeat revascularization rates. Further randomized trials, including 'all-comer' patients and registries of unselected patients are currently further evaluating the efficacy and safety of the Xience V stent in high-risk, complex cases.We also offer one of the most primary quality stents in the market, The Xience V Stent Coronary artery stents are devices (small metallic mesh tubes) that are placed over a balloon catheter and delivered to the narrowed portion of the coronary artery. The balloon is used to expand the stent. The stent presses against the narrowed vessel wall, holding the vessel open. This results in a wider artery channel to improve blood flow to the heart muscle. This may be followed by repeat balloon inflations within the stent to achieve the result desired by your doctor. Once the balloon has been deflated and withdrawn, the stent stays in place permanently, holding the coronary artery open. The inner lining of the artery grows over the surface of the stent, making the stent a permanent part of your artery
Material: nitinol(nickel+titanium), shape memory property. Anti-migration shape Flexible construction to conform to anatomy Dynamic radial force for maximum lumen size Retrievable Each of two radiopaque markers at both ends of stent Ce Varieties
